Additionally, according to the study by Keri et al., in drug-naïve persons with schizophrenia, a higher percentage of TLR4+ monocytes was associated with poorer cognitive function, as indicated by a negative correlation with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) test score. Here, TLR4 is linked to schizophrenia.